Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Adma Biologics Inc.
Headquarters: Ramsey, NJ, United States of America
Website: http://www.admabiologics.com...
Year Founded: 2004
Status: Public
Industry Sector: HealthTechnology
CEO: Adam S. Grossman
Number Of Employees: N/A
Enterprise Value: $4,152,292,292
PE Ratio: 21.99
Exchange/Ticker 1: NASDAQ:ADMA
Exchange/Ticker 2: N/A
Latest Market Cap: $4,233,745,152
BioCentury | Feb 29, 2024
Management Tracks
William Hinshaw to lead Fore
Plus: Luigi Costa passes away and updates from Corbus, Bexion, ADMA and more
BioCentury | May 8, 2020
Product Development
Japanese approval for Gilead’s remdesivir
Plus Plasma Alliance partners with NIAID; and three Chinese biotechs join to make antibody therapy
BioCentury | May 20, 2019
Financial News
May 20 Financial Quick Takes: Schrödinger tops off E round; plus Mabpharm IPO update, DNA Script, ADMA Biologics, Storm
BioCentury | Jan 4, 2019
Clinical News
FDA needs more information to approve manufacturing changes to ADMA's Bivigam
Items per page:
1 - 10 of 38